Pancreatic Cancer Research

ResearcherUniversity of MichiganNo recent work listed

Qiang Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3045-4444; OpenAlex author ID A5100381992. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper

Papers 3

  1. USP21 deubiquitinase elevates macropinocytosis to enable oncogenic KRAS bypass in pancreatic cancer. Co-author DOI 10.1101/gad.348787.121↗
  2. Transgenic expression of Sag/Rbx2 E3 causes early stage tumor promotion, late stage cytogenesis and acinar loss in the Kras-PDAC model. Co-author DOI 10.1016/j.neo.2020.03.002↗
  3. Sensitization of pancreatic cancer to chemoradiation by the Chk1 inhibitor MK8776. Co-author DOI 10.1158/1078-0432.ccr-12-3748↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Meredith Ann Morgan · 2 shared papers, 2013–2020 · strength 0.16
  2. Dongping Wei · 2 shared papers, 2013–2020 · strength 0.16
  3. Yi Sun · 1 shared paper, 2020 · strength 0.13
  4. Jianhua Zhang · 1 shared paper, 2021 · strength 0.11
  5. Yan Liang · 1 shared paper, 2021 · strength 0.11
  6. Ronald Anthony Depinho · 1 shared paper, 2021 · strength 0.11
  7. Alec C. Kimmelman · 1 shared paper, 2021 · strength 0.11
  8. Pingping Hou · 1 shared paper, 2021 · strength 0.11
  9. Wantong Yao · 1 shared paper, 2021 · strength 0.11
  10. Leslie A. Parsels · 1 shared paper, 2013 · strength 0.03
  11. Theodore Steven Lawrence · 1 shared paper, 2013 · strength 0.03
  12. Jonathan Maybaum · 1 shared paper, 2013 · strength 0.03
  13. Carl G. Engelke · 1 shared paper, 2013 · strength 0.03
  14. David M. Karnak · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.